| WHAT IS KNOWN AND OBJECTIVE
Antibiotic resistance is a global problem. It correlates with overall antibiotic use, 1 with high-consuming countries often having the highest levels of resistant organisms. [2] [3] [4] Inappropriate use of antibiotics is an established and well-recognized risk factor for the development of bacterial resistance. 5 The scale of the problem at the community level is greatest, as this is where the majority of antibiotics are prescribed. [6] [7] [8] There is, however, minimal information on stewardship interventions at a community level. Whilst hospital-based pharmacists have long been familiar with this function, the role of community pharmacists is less well established.
There are few studies that have investigated the role of community pharmacists as antibiotic stewards. A systematic search of the literature (PubMed) for studies of any design investigating any type of intervention aiming to influence antibiotic use (including prescriptions from doctors, dispensing/sales in community pharmacies or use by patients) identified only three studies describing stewardship-related interventions by community pharmacists. The studies documented the ability of community pharmacists to: use a point-of-care test to reduce antibiotic prescription 9 ; provide education to patients 10 ; and dispense antibiotics or recommend symptomatic management of patients with urinary tract infection (UTI). 11 A subsequent study also investigated the effect of pharmacist supply on antibiotic usage for UTI. 12 Pharmacist-led initiatives around the world have been documented elsewhere. 13 Other studies documented stewardship-related interventions conducted on community pharmacists. 14, 15 This relative dearth of evidence is surprising, and interventions elsewhere in primary care show the potential is great. [16] [17] [18] In a Malaysian survey of community pharmacists, nearly 90% reported they often or always communicate with prescribers where uncertainty exists over the appropriateness of antibiotic prescriptions, and over 70% often or always educate patients about antibiotic use. 19 The importance and need for antibiotic stewardship in the outpatient setting have previously been noted. 20 Community pharmacists are obvious candidate antibiotic stewards, and this commentary explores this further, focusing on upper respiratory tract infection (URTI).
| COMMENT

| URTIs are the perfect candidate
A large proportion of inappropriate antibiotic use or overuse occur in URTIs, 21, 22 which are amongst the most common acute problems encountered in primary care. 
| GRIP
The Global Respiratory Infection Partnership (GRIP)-an international group of healthcare professionals from primary care and hospitals, including doctors, microbiologists, pharmacists and researchers-was created to promote antimicrobial stewardship and facilitate multistakeholder commitment to appropriate antibiotic use for URTIs. GRIP is committed to evidence-based advocacy and intervention for rational antibiotic use, and antimicrobial stewardship and the facilitation of multistakeholder commitment to achieve this, as well as the formulation of a framework for nonantibiotic treatment options for URTIs as a prototype. 35 The framework, based on the 5Ps, encompasses policy (to advance antibiotic stewardship and conservation, and encourage symptomatic management of URTIs), prevention (of resistance, by the rational use of antibiotics), prescriber guidance (on antibiotic stewardship and effective dialogue with patients), pharmacy leadership (in the provision of advice to prescribers and patients) and patient empowerment (on self-management). 36 Pharmacists-the primary custodians of medicines-are key players in the 5P framework. 
| The COM-B model
To reduce inappropriate antibiotic use for URTI, it is important to understand the key behaviours (who needs to do what differently, when, where and how). Considering that behaviour occurs as an interaction between capability, opportunity and motivation 37 can facilitate this understanding. GRIP endorses the capability, opportunity and motivation for behaviour change (COM-B) model 37 for antibiotic stewardship by community pharmacists as they clearly possess its three key components ( Figure 1A ).
| Community pharmacists have the capability for antibiotic stewardship
As primary custodians of medicines, and with their specialist knowledge of the pathophysiology of infections, indications for prescription and non-prescription medicines, and the rational use of antibiotics (which drug, which dose and which duration), community pharmacists obviously have the capability for antibiotic stewardship. Capability can be enhanced by environmental restructuring, restrictions and modelling ( Figure 1B ).
| Community pharmacists have the opportunity for antibiotic stewardship
Owing to the contact community pharmacists have with both prescribers and patients, there are multiple opportunities for antibiotic stewardship (Table 1) . Opportunity can be enhanced by education, persuasion and incentivization ( Figure 1B) . On a wider level, political action can change attitudes around inappropriate antibiotic use, and the role of pharmacy is generally increasing.
Restriction of antibiotics to those who need them, particularly when regulation is absent or not enforced, is a critical role of the pharmacist. This is especially so in countries where antibiotics are available legally over the counter and illegally in the marketplace, and frequently through pharmacies. Even where the use of antibiotics is tightly regulated, community pharmacists could optimize antibiotic therapy by promoting adherence to treatment guidelines and compliance with treatment regimens.
With their access to both prescribers and patients, community pharmacists could be considered to be well placed to validate and confirm the need for antibiotics in consultation with the prescriber, and subsequently to advise and educate the patient on their appropriate use. For patients, community pharmacists are amongst the most accessible of healthcare providers, often being more numerous than doctors, with longer opening hours, and usually with no need for an appointment. They are often the first place patients go for advice on common health complaints and are able to advise on minor ailments with the option of referral to a doctor if necessary. 13, 39 Pharmacists are well placed to advise on patient demands for antibiotics and are experienced in the provision of non-prescription medicines for the self-management of minor ailments. They are the last point of contact before the patient commences antibiotic treatment. Pharmacists can thus reinforce the correct treatment regimen, but also monitor and provide guidance on adverse effects and drug interactions, which could otherwise lead to non-compliance. guideline and pharmacy flip book to aid the dialogue between pharmacists and patients for the management of URTI symptoms. 40, 41 Firstly, it is important to listen to the patient, understand their main symptoms and address their concerns. 42 The way patients describe their symptoms can give some insight into severity. 43 Secondly, it is important to be vigilant and assess the severity of the patient's illness. 42 Whilst the majority of URTIs are viral, non-serious and selflimiting, 44 patients at high-risk of complications, presenting with red flag symptoms or who appear severely unwell, require referral to a doctor. 41 Thirdly, patients should be counselled on effective self-management where appropriate. throat. 47 These data can reassure healthcare providers that sore throat is self-limiting, 44 even when streptococcal infection is confirmed. 
